Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-16, Stock:LLY, The news for the past five days is as follows:
2019-04-09: NEWS1: Heated debate over high drug costs returns to Capitol Hill.NEWS2: United Therapeutics Discontinues PAH Drug After Study Fails.NEWS3: United Therapeutics Discontinues PAH Drug After Study Fails.NEWS4: United Therapeutics Discontinues PAH Drug After Study Fails.
2019-04-10: NEWS1: Top Stock Reports for Eli Lilly, Altria & Becton Dickinson.NEWS2: Top Stock Reports for Eli Lilly, Altria & Becton Dickinson.NEWS3: Lilly Confirms Date and Conference Call for First-Quarter 2019 Financial Results Announcement.NEWS4: Is AstraZeneca Stock Worth Buying Before Earnings?.NEWS5: Is AstraZeneca Stock Worth Buying Before Earnings?.NEWS6: Top Stock Reports for Eli Lilly, Altria & Becton Dickinson.NEWS7: Looking for a Growth Stock? 3 Reasons Why Lilly (LLY) is a Solid Choice.NEWS8: Looking for a Growth Stock? 3 Reasons Why Lilly (LLY) is a Solid Choice.NEWS9: Why Eli Lilly (LLY) is a Great Dividend Stock Right Now.NEWS10: Why Eli Lilly (LLY) is a Great Dividend Stock Right Now.NEWS11: Is AstraZeneca Stock Worth Buying Before Earnings?.NEWS12: Sanofi sets a fixed price of insulin at $99 per month for some patients.NEWS13: Sanofi sets a fixed price of insulin at $99 per month for some patients.NEWS14: Why Eli Lilly (LLY) is a Great Dividend Stock Right Now.NEWS15: Looking for a Growth Stock? 3 Reasons Why Lilly (LLY) is a Solid Choice.NEWS16: Sanofi to cut U.S. insulin costs for some patients to $99 per month.
2019-04-11: NEWS1: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS2: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS3: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS4: The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors.NEWS5: The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors.NEWS6: Eli Lilly Stock Was Downgraded Because Everyone Already Knows It’s Good.NEWS7: The Zacks Analyst Blog Highlights: Eli Lilly, Altria, Becton, Dickinson, T-Mobile and General Motors.NEWS8: Here are the biggest analyst calls of the day: Apple, Chipotle, IBM, Xerox, U.S. Steel & more.NEWS9: Here are the biggest analyst calls of the day: Apple, Chipotle, IBM, Xerox, U.S. Steel & more.NEWS10: Algorithms, Derivatives and Manias- A Day of Reckoning.
2019-04-12: NEWS1: ACWI, LLY, ABBV, ACN: ETF Inflow Alert.NEWS2: ACWI, LLY, ABBV, ACN: ETF Inflow Alert.
2019-04-15: NEWS1: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.NEWS2: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.NEWS3: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.

Answer: Decrease